Tectonic Therapeutic | AVRO - Ebitda


Tectonic Therapeutic reported $-21.18M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Akebia Therapeutics USD 14.03M 17.19M Mar/2025
Alnylam Pharmaceuticals USD 245.34M 59.15M Jun/2026
Celltrion KRW 19.64B 1.85B Mar/2026
Cspc Pharmaceutical CNY 2.19B 21.88M Dec/2024
Deva Holding AS TRY 882.9M 201.7M Sep/2023
Dianthus Therapeutics USD -46.46M 6.27M Mar/2026
Divis Laboratories Ltd INR 12.62B 3.28B Jun/2026
Gilead Sciences USD 3.51B 489M Mar/2026
Ionis Pharmaceuticals USD -64.53M 135.49M Mar/2026
Kangmei Pharma CNY -12.72M 30.02M Mar/2026
Karyopharm Therapeutics USD -26.2M 1.83M Sep/2024
Knight Therapeutics CAD 24.45M 3.46M Dec/2025
Laboratorios Farma EUR 34.94M 102.95M Jun/2025
MacroGenics USD -30.2M 52.15M Mar/2026
Malin Corporation EUR -1.1M 200K Dec/2024
Medical Developments International AUD 1.78M 3.78M Dec/2024
Neuren Pharmaceuticals AUD 11.14M 165.56M Dec/2025
Organigram Holdings CAD -4.76M 10.02M Mar/2026
Pfizer USD 6.01B 18M Jun/2026
Pharma Mar EUR 700K 2.01M Jun/2026
Qiagen NV USD 207.66M 59.56M Jun/2026
Roche Holding CHF 13.43B 744M Jun/2026
Sanofi EUR 3.69B 375M Jun/2026
Sarepta Therapeutics USD 375.48M 627.68M Mar/2026
Sartorius EUR 280.5M 13.2M Jun/2026
Sino Biopharmaceutical CNY 2.59B 1.57B Dec/2024
Takeda JPY 364.46B 214.21B Jun/2026
Tilray USD 8.36M 1.82M Sep/2025
Zealand Pharma A/S -379M 348.47M Mar/2026
Zhangzhou Pientzehuang Pharmaceutical CNY 882.7M 351.1M Mar/2026